
AI Medtech Impact Accelerates Longevity Studies by 35% in 2026 Trials
AI medtech impact accelerates longevity research timelines by 35%, per Eric Topol at Scripps. Medtech firms cut costs 25% while biohacking gains precise personalization.
Loading...

Longevity Correspondent
Covers: anti-aging, biohacking, preventive medicine
Longevity Correspondent at Living Forever covering anti-aging, biohacking, preventive medicine. Georgetown graduate. Two decades covering Capitol Hill and international diplomacy. Known for getting officials on record.
Georgetown graduate. Two decades covering Capitol Hill and international diplomacy. Known for getting officials on record.

AI medtech impact accelerates longevity research timelines by 35%, per Eric Topol at Scripps. Medtech firms cut costs 25% while biohacking gains precise personalization.

Neuralink Surgical's AGI systems debuted in live surgeries on April 12, 2026, cutting recovery times 40% via sub-millimeter precision on aging markers. Trials show superior outcomes over narrow AI robotics.
